Delayed Coronary Obstruction After TAVR: A Complication We Had Not Considered

Delayed coronary obstruction (after TAVR, outside the cath lab) is a rare complication with high mortality rates, not unlike acute obstruction. Cardiologists should be expectant and, upon the slightest suspicion of this complication, patients should be brought back to the cath lab for a coronary angiography.

Transcatheter Valve Replacement in the Bicuspid Valve Is Increasingly Performed, but Challenges RemainOcclusion immediately after implant release has been well-studied and described (risk factors, prevention techniques, more akin devices, etc.), but we ignored that this event can take place even months after the procedure.

 

Data for this work were retrospectively collected from an international multicenter registry between 2005 and 2016.

 

During the study period, 38 delayed coronary obstructions (incidence 0.22%) were observed after TAVR from a total of 17,092 patients. Occlusions were more common after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and in cases in which self-expandable valves were used during the index procedure (0.36% vs. 0.11% for balloon-expandable; p < 0.01).


Read also: Permanent Pacemaker: still TAVR’s Aquila’s Heel.


Delayed occlusion was most frequent within 24 hours from the procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 hours and 7 days, and the remaining 14 (36.8%) occurred within 60 days.

 

The most frequent presentation was cardiac arrest (31.6%), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was the culprit vessel in most cases (92.1%).

 

Stent implantation in this registry was successful in about 70% of all patients, thus indicating that angioplasty should be attempted whenever possible.


Read also: Which Low-Flow, Low-Gradient Patients Benefit from Valve Replacement?


In-hospital mortality reached 50% and was higher among patients who experienced the event within 7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).

 

Conclusion

Delayed coronary occlusion following TAVR is a rare phenomenon with an extremely high mortality rate. Angioplasty should be attempted whenever possible, since stent implantation was successful in about 70% of all cases.

 

Original title: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement.

Reference: Richard J. Jabbour et al. J Am Coll Cardiol 2018;71:1513-24.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

 The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...